Sam Altman invested $180M into a company trying to delay death
technologyreview.com
technologyreview.com
Good luck to Altman, except with that silly thing called Worldcoin.
buried deep in the article is a half-sentence description of what they are actually trying to do:
> the company instead hopes to find more “plausible” interventions, like drugs that mimic the effects of blood replacement and could be used by millions of people